FLSM
IBIO icon

Frazier Life Sciences Management’s iBio IBIO Stock Holding History

Frazier Life Sciences Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42M Hold
1,953,467
– – 0.07% 41
2026
Q1 		$3.71M Hold
1,953,467
– – 0.1% 37
2025
Q4 		$3.77M Buy
+1,953,467
New +$2.67M 0.1% 40

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Frazier Life Sciences Management's IBIO Position: Q2 2026 in Review

Frazier Life Sciences Management held its iBio (IBIO) position steady in Q2 2026 at 1,953,467 shares worth $3.42M. The position accounts for 0.07% of the portfolio, ranked #41.

Frazier Life Sciences Management first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.77M in Q4 2025. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Frazier Life Sciences Management held 1,953,467 shares of iBio worth $3.42M as of Q2 2026.
  • Frazier Life Sciences Management left its iBio share count unchanged in Q2 2026.
  • iBio made up 0.07% of Frazier Life Sciences Management's portfolio in Q2 2026, its #41 holding.
  • Frazier Life Sciences Management first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • Frazier Life Sciences Management's iBio position peaked at $3.77M in Q4 2025.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Frazier Life Sciences Management's 13F filing for Q2 2026, filed 14 Aug 2026.